Lexicon Pharmaceuticals Q2 EPS $0.01 Beats $(0.08) Estimate, Sales $28.866M Beat $4.867M Estimate

Author: Benzinga Newsdesk | August 06, 2025 07:41am
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.08) by 112.99 percent. This is a 105.88 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $28.866 million which beat the analyst consensus estimate of $4.867 million by 493.04 percent. This is a 1.65K percent increase over sales of $1.647 million the same period last year.

Posted In: LXRX